MODIFIED LABYSYSTEMS' TOXOPLASMA GONDII IGG EIA— 510(k) K890154

Name: FDA 510(k) clearance K890154
Creator: U.S. Food and Drug Administration
Published: 1989-02-07

Substantially Equivalent

Labsystems, Inc.

FDA 510(k) clearance K890154 for MODIFIED LABYSYSTEMS' TOXOPLASMA GONDII IGG EIA, Substantially Equivalent on 1989-02-07. Applicant: Labsystems, Inc.. Device class: 2.

Clearance details

Applicant: Labsystems, Inc.
Product code: Code LGD
Device class: Class 2
Regulation: 21 CFR 866.3780
Advisory panel: Microbiology
Date received: 1989-01-12
Decision date: 1989-02-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Finland, FI

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGD

view all

K242022 — Access Toxo IgG2025-03-28
K242095 — Access Toxo IgM II2024-10-11
K233932 — Alinity i Toxo IgM2024-08-30
K210596 — ARCHITECT Toxo IgG2022-05-19
K162678 — Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl2017-06-23

More clearances from Labsystems, Inc.

view all

K923365 — TILT/REDUCED SHEAR SEMI-RECLINE SEATING SYSTEM1993-03-24
K896474 — RESUBMITTED FECATWIN SENSITIVE - FECA-EIA1990-01-25
K890091 — MODIFIED LABSYSTEMS' RUBELLA IGG EIA TEST KIT1989-02-03
K881243 — RUBELLA IGG - EIA TEST KIT NUMBER 61 07 2011988-04-04
K873780 — MODIFICATION RUBELLA IGM EIA TEST KIT1987-10-15

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.